Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prolonged Air Leak (PAL) Autologous Blood Patch Intervention Trial

NCT04954625 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.

NCT NCT04954625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04954625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prolonged Air Leak (PAL) Autologous Blood Patch Intervention Trial
Lead sponsor
Rush University Medical Center
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
July 1, 2021
Completion date
December 31, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer